{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:06Z","timestamp":1780099206268,"version":"3.54.0"},"reference-count":52,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T00:00:00Z","timestamp":1216857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Thousands of patients with chronic renal failure die yearly and are unable to have a kidney transplant due to the severe shortage of donors. Therapeutic plasma exchange (TPE) is performed to remove ABO antibodies and permit ABO\u2010incompatible (ABO\u2010I) kidney transplants, but there is only limited research within this area and a lack of standardized protocols for TPE. This article reviews the literature to provide a historical perspective of TPE for ABO\u2010I kidney transplantation and also provides the Johns Hopkins Hospital protocol with a focus on both titers and TPE.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The TPE treatment plan is based on ABO titers with the goal of a titer of 16 or less at the anti\u2010human globulin (AHG) phase before surgery. Pretransplant therapy consists of every\u2010other\u2010day TPE followed immediately by cytomegalovirus hyperimmune globulin. ABO antibody titers are closely monitored before and after transplantation. After transplantation, TPE therapy is performed for all patients to prevent rebound of anti\u2010A and anti\u2010B titers until tolerance or accommodation occurs. TPE is discontinued and reinstituted based on the clinical criteria of creatinine levels, biopsy results, and ABO titer.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Fifty\u2010three ABO\u2010I kidney transplants have been completed with no episodes of hyperacute antibody\u2010mediated rejection (AMR) and only three episodes of AMR. One\u2010year death\u2010censored graft survival is 100 percent and patient survival is 97.6 percent.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> While randomized clinical trials are needed to evaluate the optimal method and protocol to remove ABO antibodies, the current literature and our results indicate a critical role for TPE in ABO\u2010I renal transplantation.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.01857.x","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T10:48:46Z","timestamp":1216896526000},"page":"2453-2460","source":"Crossref","is-referenced-by-count":77,"title":["The critical role of plasmapheresis in ABO\u2010incompatible renal transplantation"],"prefix":"10.1111","volume":"48","author":[{"given":"Aaron A.R.","family":"Tobian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Sue","family":"Shirey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,3]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.111.6.785"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1959.tb04307.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000231697.15817.51"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010073"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000129256.84027.D6"},{"key":"e_1_2_7_7_2","volume-title":"2006 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996\u20102005","year":"2006"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00496.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20129"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103085"},{"key":"e_1_2_7_11_2","first-page":"195","article-title":"Renal homografts in patients with major donor\u2010recipient blood group incompatibilities","volume":"55","author":"Starzl TE","year":"1964","journal-title":"Surgery"},{"key":"e_1_2_7_12_2","first-page":"325","article-title":"Selective plasmapheresis in dogs for delay of heterograft response","volume":"16","author":"Bier M","year":"1970","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198204000-00017"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198101000-00002"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198802000-00013"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000247503.87162.15"},{"key":"e_1_2_7_17_2","volume-title":"Technical manual","author":"Brecher ME","year":"2005"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2001.00313.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0094-0143(21)00947-2","article-title":"ABO\u2010incompatible renal transplantation","volume":"21","author":"Toma H","year":"1994","journal-title":"Urol Clin North Am"},{"key":"e_1_2_7_20_2","first-page":"4538","article-title":"Present experiences in a series of 26 ABO\u2010incompatible living donor renal allografts","volume":"19","author":"Alexandre GP","year":"1987","journal-title":"Transplant Proc"},{"key":"e_1_2_7_21_2","first-page":"138","article-title":"Splenectomy as a prerequisite for successful human ABO\u2010incompatible renal transplantation","volume":"17","author":"Alexandre GP","year":"1985","journal-title":"Transplant Proc"},{"key":"e_1_2_7_22_2","first-page":"4543","article-title":"Experiences with known ABO\u2010mismatched renal transplants","volume":"19","author":"Bannett AD","year":"1987","journal-title":"Transplant Proc"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(01)80032-X"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2005.00306.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000296103.34735.b8"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199801270-00014"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01676.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200210270-00023"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200008270-00024"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200011150-00011"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000173647.43616.78"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20002"},{"key":"e_1_2_7_33_2","first-page":"221","article-title":"Stratification and successful transplantation of patients awaiting ABO\u2010incompatible (A2 into B and O) transplantation by A\u2010isoagglutinin\u2010titer phenogroup","volume":"28","author":"Nelson PW","year":"1996","journal-title":"Transplant Proc"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199801270-00020"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812270-00025"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199905270-00005"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2004.00214.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01356.x"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00507.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00653.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01031.x"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000296032.12974.bb"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000058226.39732.32"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00147-004-0775-7"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00927.x"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000078622.43689.D4"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2006.00292.x"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00364.x"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000184622.69708.c1"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000262570.18117.55"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2004.07.004"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470986868"},{"issue":"2","key":"e_1_2_7_53_2","first-page":"157","article-title":"Variability of anti\u2010blood group titers accordng to methodology and clinical relevance in ABO\u2010incompatible renal transplantation","volume":"7","author":"Cohney SJ","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.01857.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.01857.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:58:07Z","timestamp":1697252287000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.01857.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1537-2995.2008.01857.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01857.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}